Atlas Trials

Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial

Clinical trial NCT04118699 · UNKNOWN

Trial details

NCT number
NCT04118699
Sponsor
Yokohama City University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Intestinal Pseudo-obstruction
Start date
2019-12-25
Primary completion
2021-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.